Next Step For Cancer Treatment Trial
0
The Malaghan Institute of Medical Research and BioOra Limited applied to use chimeric antigen receptor (CAR) T-cells in a phase 2 clinical trial for patients suffering from a type of blood cancer called relapsed large B-cell non-Hodgkin lymphoma.